ezogabine has been researched along with Urinary Retention in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brickel, N; DeRossett, S; Gandhi, P; Hammond, J; VanLandingham, K | 1 |
1 review(s) available for ezogabine and Urinary Retention
| Article | Year |
|---|---|
The urinary safety profile and secondary renal effects of retigabine (ezogabine): a first-in-class antiepileptic drug that targets KCNQ (K(v)7) potassium channels.
Topics: Animals; Anticonvulsants; Carbamates; Epilepsies, Partial; Humans; KCNQ Potassium Channels; Muscle, Smooth; Phenylenediamines; Urinary Retention | 2012 |